Tebbic is a biotechnology start-up dedicated to pioneering a new generation of therapeutics. We specialize in creating highly specific treatments designed to maximize therapeutic efficacy and reduce off-target toxicity. This strategy results in more tolerable medicines with significantly improved benefit-risk profiles for patients. Our current therapeutic areas of focus include oncology and pain management.